AMAG Pharma (AMAG) Posts Q2 Loss of $0.40
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Net loss before income taxes: 21.27M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net loss before income taxes: 21.27M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q2 EPS of ($0.40), which may note compare to the analyst estimate of $1.34. Revenue for the quarter came in at $159.7 million versus the consensus estimate of $158.59 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
